TickerFactsScreenerDevelopers

WEST PHARMACEUTICAL SERVICES INC (WST) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2008: $748.50M2009: $752.10M2010: $786.60M2011: $853.00M2012: $878.70M2013: $933.70M2014: $973.60M2015: $944.00M2016: $1.01B2017: $1.09B2018: $1.17B2019: $1.23B2020: $1.38B2021: $1.66B2022: $1.75B2023: $1.82B2024: $1.89B2025: $1.97B$1.97B
2008Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$1.97B+4.0%
2024$1.89B+4.1%
2023$1.82B+4.0%
2022$1.75B+5.7%
2021$1.66B+20.1%
2020$1.38B+11.7%
2019$1.23B+5.3%
2018$1.17B+7.9%
2017$1.09B+7.8%
2016$1.01B+6.7%
2015$944.00M-3.0%
2014$973.60M+4.3%
2013$933.70M+6.3%
2012$878.70M+3.0%
2011$853.00M+8.4%
2010$786.60M+4.6%
2009$752.10M+0.5%
2008$748.50M—